Holen Sie sich die Stockscreener-App
71.78
0.97%
0.6216
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GEHC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$71.16
Offen:
$71.58
24-Stunden-Volumen:
2.35M
Relative Volume:
0.51
Marktkapitalisierung:
$33.85B
Einnahmen:
$19.80B
Nettoeinkommen (Verlust:
$2.18B
KGV:
15.11
EPS:
4.75
Netto-Cashflow:
$1.37B
1W Leistung:
+1.00%
1M Leistung:
+3.89%
6M Leistung:
-9.46%
1J Leistung:
-8.88%
1-Tages-Spanne:
$71.41
$72.29
1-Wochen-Bereich:
$69.49
$72.61
52-Wochen-Spanne:
$57.65
$94.80
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Firmenname
Ge Healthcare Technologies Inc
Sektor
Branche
Telefon
833-735-1139
Adresse
500 WEST MONROE STREET, CHICAGO
Vergleichen Sie GEHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GEHC
Ge Healthcare Technologies Inc
|
71.78 | 33.85B | 19.80B | 2.18B | 1.37B | 4.75 |
|
ABT
Abbott Laboratories
|
137.13 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.67 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
385.33 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.53 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.17 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Hochstufung | UBS | Sell → Neutral |
| 2025-03-11 | Hochstufung | Goldman | Neutral → Buy |
| 2025-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-26 | Herabstufung | UBS | Neutral → Sell |
| 2024-09-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-06 | Eingeleitet | Stifel | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-02-15 | Eingeleitet | HSBC Securities | Buy |
| 2024-02-12 | Hochstufung | UBS | Sell → Neutral |
| 2023-11-30 | Eingeleitet | Jefferies | Hold |
| 2023-11-27 | Herabstufung | UBS | Neutral → Sell |
| 2023-09-19 | Eingeleitet | Citigroup | Buy |
| 2023-08-25 | Eingeleitet | Argus | Buy |
| 2023-08-16 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-31 | Eingeleitet | BofA Securities | Neutral |
| 2023-06-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-26 | Eingeleitet | UBS | Neutral |
| 2023-04-19 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-10 | Eingeleitet | BTIG Research | Neutral |
| 2023-03-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-02-17 | Eingeleitet | Mizuho | Buy |
| 2023-01-19 | Eingeleitet | Redburn | Buy |
Alle ansehen
Ge Healthcare Technologies Inc Aktie (GEHC) Neueste Nachrichten
GE HealthCare: More Tariff Challenges Coming Ahead; Initiate With ‘Sell’ (NASDAQ:GEHC) - Seeking Alpha
Is GE HealthCare Technologies Stock Underperforming the Nasdaq? - MSN
GE HealthCare Stock Slips Despite the Launch of bkActiv S Series - Yahoo Finance
Major Player in the Medical Radiation Dose Monitoring Market - openPR.com
Bioreactors Market Hits New High | Major Giants GE Healthcare, Pall Corporation, Eppendorf - openPR.com
Mayo Clinic, GE HealthCare, Virtua to speak at Leadership Summit - Modern Healthcare
GE HealthCare launches next-gen intraoperative ultrasound - MassDevice
GE HealthCare Releases bkActiv S Series Intraoperative Ultrasounds - Medical Product Outsourcing
Weight Monitoring and Body Temperature Monitoring Devices - openPR.com
GEHC Stock Declines Despite Expansion in Precision Care Capabilities - TradingView
BTIG reiterates buy rating on GE HealthCare stock, citing stable growth - Investing.com Nigeria
GE HealthCare Technologies Inc. (GEHC) Stock Forecasts - Yahoo
GE HealthCare integrates proprietary features with MIM Encore software By Investing.com - Investing.com India
GE Healthcare Launches Enhanced Version of MIM Encore Imaging Software - Diagnostic and Interventional Cardiology
GE HealthCare integrates its imaging tech with MIM Software tools - Modern Healthcare
GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software - MassDevice
GE HealthCare Technologies (NasdaqGS:GEHC) Enhances Diagnostic Confidence With MIM Encore Integration - Yahoo Finance
GE HealthCare and MIM Software release integrated imaging platform - Yahoo Finance
GE HealthCare Reveals MIM Encore Digital Imaging and Workflow Tools - Medical Product Outsourcing
GE HealthCare integrates proprietary features with MIM Encore software - Investing.com Australia
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions - Business Wire
Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization - TipRanks
Is GE HealthCare Technologies Stock Underperforming The Nasdaq? - Barchart.com
$101.5 Bn Oncology Diagnostics Global Markets, 2023-2024 & - GlobeNewswire
GE HealthCare issues $1.5 billion in senior notes By Investing.com - Investing.com Nigeria
GE HealthCare issues $1.5 billion in senior notes - Investing.com Australia
GE Healthcare Issues $1.5 Billion in Senior Notes - TipRanks
Capital Research Global Reports 4.8% Passive Stake In GE Healthcare As Of May 30 - MarketScreener
A closer look at GE HealthCare's new affordable cardiac CT scanner - Cardiovascular Business
Tata Memorial Centre ties up with Wipro GE to set up cancer research centre - Business Standard
Tata Memorial Centre and Wipro GE HealthCare Partner to Launch Cancer Research & Innovation Centre in India - eHealth Magazine
Wipro GE HealthCare inks MoU with Tata Memorial Centre to establish Cancer Research & Innovation Centre - BioSpectrum India
GE HealthCare inks MoU with Tata Memorial Centre to establish Cancer Research & Innovation Centre - BioSpectrum India
Tata Memorial Centre signs MoU with GE HealthCare for advanced cancer research - Healthcare Radius
GE HealthCare: The Demand Is Just Too Strong To Ignore (NASDAQ:GEHC) - Seeking Alpha
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks - The Motley Fool
GE Healthcare Announces $1.5 Billion Notes Offering - TipRanks
Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.
Tata Memorial Centre signs MoU with GE Healthcare to set up cancer research centre at TMC Mumbai - BusinessLine
Tata Memorial Centre, Wipro GE HealthCare sign MoU to Establish Cancer Research & Innovation Centre - ET HealthWorld
Tata Memorial, GE HealthCare Partner for Cancer Research - Rediff MoneyWiz
Tata Memorial Centre signs MoU with GE HealthCare to establish ‘Cancer Research & Innovation Centre’ - Pharmabiz.com
GE HealthCare Files For Offering Of $650 Million 4.800% Senior Notes Due 2031 - marketscreener.com
GE HealthCare Technologies : Kalbe and GE HealthCare Launch Indonesia’s First CT-Scanner Production Facility - marketscreener.com
North America 3D 4D Technology Market Size, Share Projections - openPR.com
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer - Quantisnow
DBS Bank Adjusts Price Target on GE Healthcare Technologies to $90 From $80, Maintains Buy Rating - marketscreener.com
GE HealthCare Technologies (GEHC): Company Profile, Stock Price, News, Rankings - Fortune
Wall Street Zen Upgrades GE HealthCare Technologies (NASDAQ:GEHC) to “Buy” - Defense World
GE Healthcare Says Updated NCCN Guidelines Recommend Use of FES PET Imaging for Breast Cancer - marketscreener.com
GE HealthCare secures stockholder approval for executive pay - Investing.com India
Finanzdaten der Ge Healthcare Technologies Inc-Aktie (GEHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ge Healthcare Technologies Inc-Aktie (GEHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rott Roland | CEO, Imaging |
Nov 05 '24 |
Option Exercise |
40.40 |
13,275 |
536,310 |
37,573 |
| Rott Roland | CEO, Imaging |
Nov 06 '24 |
Sale |
86.48 |
3,577 |
309,339 |
24,298 |
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):